Breast Cancer | Specialty

The OncLive Breast Cancer condition center page is a comprehensive resource for clinical news and expert insights on various types of breast cancer, including those that are triple negative, hormone receptor positive, and/or HER2 positive. This page features news articles, interviews in written and video format, and podcasts that focus on treatment advances and ongoing research in breast cancer.

Dr. Perou on Next Generation Sequencing Technology

March 30th 2012

Dr. Charles Perou, from the UNC Lineberger Comprehensive Cancer Center, on Next Generation Sequencing Technology

Dr. Gralow on Treating Breast Cancer Bone Metastases

March 29th 2012

Dr. Julie Gralow, from the Seattle Cancer Care Alliance, on Treating Breast Cancer Bone Metastases

Molecular Profiling Helps Determine Use of New Therapeutic Agents in Breast Cancer

March 29th 2012

For locally advanced breast cancer, molecular profiling may be an effective way to determine which patients respond better to certain therapies.

Dr. Perez on Patient Selection for Adjuvant Chemotherapy

March 28th 2012

Dr. Edith Perez, from the Mayo Clinic Cancer Center, Discusses Adjuvant Chemotherapy Patient Selection

Dr. Ellis Describes Breast Cancer Heterogeneity

March 27th 2012

Dr. Matthew Ellis, from Siteman Cancer Center, Describes Breast Cancer Heterogeneity

Supreme Court Asks for Reconsideration on BRCA1 and BRCA2 Patents

March 27th 2012

The US Supreme Court has asked an appellate court to reconsider its decision regarding patents held on two genes.

Examining the HER2 Testing Puzzle: Fresh Research Explores Nagging Questions

March 27th 2012

HER2 status in patients with breast cancer has emerged as a durable and effective marker for evaluating tumors and selecting therapies.

Dr. Spector Discusses the Complexities of Cancer

March 26th 2012

Dr. Neil Spector, from the Duke Cancer Institute, Discusses the Complexities of Cancer

Dr. Davidson Discusses Breast Cancer Chemoprevention

March 23rd 2012

Dr. Nancy Davidson, from the University of Pittsburgh Cancer Institute, Discusses Breast Cancer Chemoprevention

Dr. Chang on Combining HER2 Targeted Therapies

March 22nd 2012

Dr. Jenny Chang, from the Methodist Cancer Center, Discusses Combining HER2 Targeted Therapies

Dr. Borgen on the Negative Effects of Pinkwashing

March 20th 2012

Dr. Patrick Borgen, from the Maimonides Breast Cancer Center, Discusses the Negative Effects of Pinkwashing

Surgical Breast Biopsy Not Overused, Study Suggests

March 19th 2012

Contrary to earlier findings, surgical breast biopsies may not be as overused as previously thought, according to a recent study published in the Journal of the American College of Radiology.

Dr. Tripathy Discusses Breast Cancer Prevention

March 16th 2012

Dr. Debu Tripathy, from the USC Norris Comprehensive Cancer Center, Discusses Breast Cancer Prevention

Emerging Therapies for HER2-Positive and Triple-Negative Breast Cancers

March 16th 2012

Recognition of breast cancer subtypes and research into their underlying biologies is driving the development of new therapies.

Dr. Gralow on Breast Cancer Adjuvant Bisphosphonates

March 16th 2012

Dr. Julie Gralow, from the Seattle Cancer Care Alliance, on Adjuvant Bisphosphonates for Breast Cancer

Immunotherapy Emerges as Promising Strategy in Breast Cancer

March 16th 2012

Next-generation immunotherapy in breast cancer treatment is an active field of scientific exploration with the potential to yield a vaccine.

Dr. Osman on the 29th Miami Breast Cancer Conference

March 15th 2012

Dr. Daniel Osman, the program chair for the Miami Breast Cancer Conference, Discusses the 29th Annual Meeting

Advances in Genomics Mask Complexities

March 15th 2012

Technological advances in genomics have prompted a "sea change" in breast cancer drug development and treatment.

Patients, Surgeons Face Hurdles in Making Breast Cancer Decisions

March 15th 2012

The choice of breast-conserving surgery over mastectomy is often based on fear of recurrence and death rather than clinical evidence.

Four Key Areas Are Focus of ASCO/SABCS Highlights

March 14th 2012

Debu Tripathy, MD, culled the highlights from abstracts presented in 2011 at the ASCO annual meeting in Chicago, Illinois, and at the CCTR-AARC SABCS in Texas.